Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Researchers Develop Strategy to Replace Diseased Blood System Affected by Leukemia

Researchers Develop Strategy to Replace Diseased Blood System Affected by Leukemia

Machine Learning Program Offers Insights Into Promoter Sequences and Transcription

Machine Learning Program Offers Insights Into Promoter Sequences and Transcription

Syntekabio to Unveil Novel Biologics Platform at 20th Annual PEGS Boston Summit

Syntekabio to Unveil Novel Biologics Platform at 20th Annual PEGS Boston Summit

St. Jude Scientists Reveal Role of Non-Coding DNA Variants in Childhood Leukemia

St. Jude Scientists Reveal Role of Non-Coding DNA Variants in Childhood Leukemia

Precision Combination Therapy Better Controls High-Risk Subtypes of B-ALL in Mouse Models

Precision Combination Therapy Better Controls High-Risk Subtypes of B-ALL in Mouse Models

Research Sheds Light on Blood Cell Production in Mouse Skeleton

Research Sheds Light on Blood Cell Production in Mouse Skeleton

U of T Researchers Develop Groundbreaking Platform for Protein-Based Disease Treatment

U of T Researchers Develop Groundbreaking Platform for Protein-Based Disease Treatment

Dual-Target CAR T Cell Therapy Shows Promise Against Recurrent Glioblastoma

Dual-Target CAR T Cell Therapy Shows Promise Against Recurrent Glioblastoma

Mechanism of Cancer Drug Targeting Tumor Suppressor Genes Unveiled

Mechanism of Cancer Drug Targeting Tumor Suppressor Genes Unveiled

RNA-Seq Unveils Molecular Subtypes for Tailored Pediatric B-ALL Treatment

RNA-Seq Unveils Molecular Subtypes for Tailored Pediatric B-ALL Treatment

Boosting Post-Transplant Survival: Tailoring Gut Microbiome to Fight GvHD

Boosting Post-Transplant Survival: Tailoring Gut Microbiome to Fight GvHD

AI Program Reveals Cellular Neighborhoods in Cancer Microenvironments

AI Program Reveals Cellular Neighborhoods in Cancer Microenvironments

Microbial Sensor Unlocks Path to Personalized Blood Stem Cell Therapy

Microbial Sensor Unlocks Path to Personalized Blood Stem Cell Therapy

Microbial Sensor Plays Key Role in Blood Stem Cell Development

Microbial Sensor Plays Key Role in Blood Stem Cell Development

Study Elucidates How Mutant NPM1 Protein Drives Leukemia by Activating Autophagy System

Study Elucidates How Mutant NPM1 Protein Drives Leukemia by Activating Autophagy System

New Irreversible Inhibitor Overcomes Drug Resistance in Cancer Cells

New Irreversible Inhibitor Overcomes Drug Resistance in Cancer Cells

Nutrient Derived From Meat and Dairy Enhances Cancer Killing Ability of Immune Cells

Nutrient Derived From Meat and Dairy Enhances Cancer Killing Ability of Immune Cells

Gene Splicing Affects CD20 Expression and Response to Cancer Immunotherapy

Gene Splicing Affects CD20 Expression and Response to Cancer Immunotherapy

Wilmot Researchers Uncover a "Genomic Tug of War" That Influences Decitabine's Effectiveness

Wilmot Researchers Uncover a "Genomic Tug of War" That Influences Decitabine's Effectiveness

New Insights Into Tumor-Immune Interactions Could Lead to More Effective Therapies for Multiple Myeloma

New Insights Into Tumor-Immune Interactions Could Lead to More Effective Therapies for Multiple Myeloma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.